Description
EMPA M Tablets 12.5mg + 500mg (14’s pack) combine two effective agents, Empagliflozin and Metformin, to help manage type 2 diabetes. Each tablet contains 12.5mg of Empagliflozin and 500mg of Metformin, working together to improve blood sugar control and support overall metabolic health.
Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, reduces glucose reabsorption in the kidneys, promoting excess glucose removal via urine. Metformin, a biguanide, decreases glucose production in the liver and enhances insulin sensitivity, making this combination highly effective for glycemic management.
This 14-tablet pack offers a convenient dosage regimen for patients requiring combination therapy. EMPA M Tablets are manufactured following stringent quality standards to ensure safety, efficacy, and consistent therapeutic performance.
Patients should take these tablets as prescribed by their healthcare provider and maintain a healthy lifestyle, including diet and exercise, to maximize benefits. Regular medical supervision is recommended to monitor treatment progress and adjust dosages if necessary.
EMPA M Tablets 12.5mg + 500mg provide a reliable and well-tolerated option for improving blood sugar control in adults with type 2 diabetes.
Reviews
There are no reviews yet.